Cargando…
IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease
Many people living with diabetes also have nonalcoholic fatty liver disease (NAFLD). Interleukin-6 (IL-6) is involved in both diseases, interacting with both membrane-bound (classical) and circulating (trans-signaling) soluble receptors. We investigated whether secretion of IL-6 trans-signaling core...
Autores principales: | Gunes, Aysim, Schmitt, Clémence, Bilodeau, Laurent, Huet, Catherine, Belblidia, Assia, Baldwin, Cindy, Giard, Jeanne-Marie, Biertho, Laurent, Lafortune, Annie, Couture, Christian Yves, Cheung, Angela, Nguyen, Bich N., Galun, Eithan, Bémeur, Chantal, Bilodeau, Marc, Laplante, Mathieu, Tang, An, Faraj, May, Estall, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658070/ https://www.ncbi.nlm.nih.gov/pubmed/37757741 http://dx.doi.org/10.2337/db23-0171 |
Ejemplares similares
-
Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver
por: Jelenik, Tomas, et al.
Publicado: (2017) -
Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
por: Shirakawa, Jun, et al.
Publicado: (2011) -
Genetic Ablation of cGMP-Dependent Protein Kinase Type I Causes Liver Inflammation and Fasting Hyperglycemia
por: Lutz, Stefan Z., et al.
Publicado: (2011) -
TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
por: Menghini, Rossella, et al.
Publicado: (2012) -
Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
por: Heebøll, Sara, et al.
Publicado: (2022)